iRhythm Technologies Inc
NASDAQ:IRTC
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
57.07
123.61
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
iRhythm Technologies Inc
iRhythm Technologies Inc
Capital Expenditures
iRhythm Technologies Inc
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
iRhythm Technologies Inc
NASDAQ:IRTC
|
Capital Expenditures
-$55.6m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Capital Expenditures
-$725m
|
CAGR 3-Years
15%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-1%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Capital Expenditures
-$780m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-10%
|
|
|
Stryker Corp
NYSE:SYK
|
Capital Expenditures
-$634m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-11%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Capital Expenditures
-$2.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-7%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Capital Expenditures
-$1.2B
|
CAGR 3-Years
-67%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-33%
|
|
iRhythm Technologies Inc
Glance View
iRhythm Technologies, Inc. engages in the development of monitoring and diagnostic solutions for detection of cardiac arrhythmias. The company is headquartered in San Francisco, California and currently employs 1,700 full-time employees. The company went IPO on 2016-10-20. The firm has developed a portfolio of ambulatory cardiac monitoring services on a platform, called the Zio service. Zio service consists of wearable patch-based biosensors, Zio XT and Zio AT monitors, which records and stores ECG data from every patient heartbeat for up to 14 consecutive days. Zio service then provides cloud-based analysis of the recorded cardiac rhythms using its algorithms, an assessment review of the data by its cardiographic technicians, a report called Zio report, which includes the summary of findings and finally its cloud-based digital information system, ZioSuite, allows clinicians to connect via a Web browser or mobile application for online report interpretation and clinical workflows. The firm's cloud-based data analytic platform to help physicians monitor patients and diagnose arrhythmias.
See Also
What is iRhythm Technologies Inc's Capital Expenditures?
Capital Expenditures
-55.6m
USD
Based on the financial report for Sep 30, 2024, iRhythm Technologies Inc's Capital Expenditures amounts to -55.6m USD.
What is iRhythm Technologies Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-41%
Over the last year, the Capital Expenditures growth was -64%. The average annual Capital Expenditures growth rates for iRhythm Technologies Inc have been -29% over the past three years , -41% over the past five years .
You don't have any saved screeners yet
